Simple Microwire and Microcatheter Mechanical Thrombolysis with Adjuvant Intraarterial Urokinase for Treatment of Hyperacute Ischemic Stroke Patients

References

• Furlan A., Higashida R., Wechsler L., Gent M., Rowley H., Kase C., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003–11
   PubMed Web of Science ®Google Scholar
• Ringer A. J., Qureshi A. I., Fessler R. D., Guterman L. R., Hopkins L. N. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001; 48: 1282–8; discussion 1288–90
   PubMed Web of Science ®Google Scholar
• Sorimachi T., Fujii Y., Tsuchiya N., Nashimoto T., Harada A., Ito Y., et al. Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. Am J Neuroradiol 2004; 25: 1391–402
   PubMed Web of Science ®Google Scholar
• Gobin Y. P., Starkman S., Duckwiler G. R., Grobelny T., Kidwell C. S., Jahan R., et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004; 35: 2848–54
   PubMed Web of Science ®Google Scholar
• Qureshi A. I., Siddiqui A. M., Suri M. F., Kim S. H., Ali Z., Yahia A. M., et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002; 51: 1319–27
   PubMed Web of Science ®Google Scholar
• Kim D. J., Kim D. I., Kim S. H., Lee K. Y., Heo J. H., Han S. W. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Neuroradiology 2005; 47: 616–21
   PubMed Web of Science ®Google Scholar
• The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985; 312: 932–6
   PubMed Web of Science ®Google Scholar
• Arnold M., Schroth G., Nedeltchev K., Loher T., Remonda L., Stepper F., et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002; 33: 1828–33
   PubMed Web of Science ®Google Scholar
• Keeley E. C., Boura J. A., Grines C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13–20
   PubMed Web of Science ®Google Scholar
• Mitchel J. F., Shwedick M., Alberghini T. A., Knibbs D., McKay R. G. Catheter-based local thrombolysis with urokinase: comparative efficacy of intraluminal clot lysis with conventional urokinase infusion techniques in an in vivo porcine thrombus model. Cathet Cardiovasc Diagn 1997; 41: 293–302
   PubMedGoogle Scholar
• Jahan R., Duckwiler G. R., Kidwell C. S., Sayre J. W., Gobin Y. P., Villablanca J. P., et al. Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. Am J Neuroradiol 1999; 20: 1291–9
   PubMed Web of Science ®Google Scholar
• Suarez J. I., Zaidat O. O., Sunshine J. L., Tarr R., Selman W. R., Landis D. M. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 2002; 50: 251–9
   PubMed Web of Science ®Google Scholar
• Noser E. A., Shaltoni H. M., Hall C. E., Alexandrov A. V., Garami Z., Cacayorin E. D., et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke?. Stroke 2005; 36: 292–6
   PubMed Web of Science ®Google Scholar
• Barnwell S. L., Clark W. M., Nguyen T. T., O'Neill O. R., Wynn M. L., Coull B. M. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. Am J Neuroradiol 1994; 15: 1817–22
   PubMed Web of Science ®Google Scholar
• Nakano S., Iseda T., Yoneyama T., Kawano H., Wakisaka S. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 2002; 33: 2872–6
   PubMed Web of Science ®Google Scholar
• Poncyljusz W., Falkowski A., Kojder I., Cebula E., Sagan L., Czechowski J., et al. Treatment of acute ischemic brain infarction with the assistance of local intraarterial thrombolysis with recombinant tissue-type plasminogen activator. Acta Radiol 2007; 48: 774–80
   PubMed Web of Science ®Google Scholar
• Smith W. S., Sung G., Starkman S., Saver J. L., Kidwell C. S., Gobin Y. P., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432–8
   PubMed Web of Science ®Google Scholar
• Yoneyama T., Nakano S., Kawano H., Iseda T., Ikeda T., Goya T., et al. Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion. Am J Neuroradiol 2002; 23: 277–81
   PubMed Web of Science ®Google Scholar
• Tomsick T. A. Mechanical embolus removal: a new day dawning. Stroke 2005; 36: 1439–40
   PubMed Web of Science ®Google Scholar
• Zarich S. W., Kowalchuk G. J., Weaver W. D., Loscalzo J., Sassower M., Manzo K., et al. Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial. J Am Coll Cardiol 1995; 26: 374–9
   PubMed Web of Science ®Google Scholar
• Morris J. A., Muller D. W., Topol E. J. Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase. Am Heart J 1991; 122: 375–80
   PubMed Web of Science ®Google Scholar
• Lee K. Y., Kim D. I., Kim S. H., Lee S. I., Chung H. W., Shim Y. W., et al. Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. Am J Neuroradiol 2004; 25: 1470–5
   PubMed Web of Science ®Google Scholar
• Shaltoni H. M., Albright K. C., Gonzales N. R., Weir R. U., Khaja A. M., Sugg R. M., et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?. Stroke 2007; 38: 80–4
   PubMed Web of Science ®Google Scholar
• Hill M. D., Barber P. A., Demchuk A. M., Newcommon N. J., Cole-Haskayne A., Ryckborst K., et al. Acute intravenous–intra-arterial revascularization therapy for severe ischemic stroke. Stroke 2002; 33: 279–82
   PubMed Web of Science ®Google Scholar
• Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004; 35: 904–11
   PubMed Web of Science ®Google Scholar
• Labiche L. A., Al-Senani F., Wojner A. W., Grotta J. C., Malkoff M., Alexandrov A. V. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003; 34: 695–8
   PubMed Web of Science ®Google Scholar